SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950142-18-000853
Filing Date
2018-04-09
Accepted
2018-04-09 16:10:17
Documents
1
Group Members
AISLING CAPITAL IV, LPAISLING CAPITAL PARTNERS IV LLCAISLING CAPITAL PARTNERS IV, LPANDREW SCHIFFSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G eh1800537_13g-zosano.htm SC 13G 162803
  Complete submission text file 0000950142-18-000853.txt   164525
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Subject) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88596 | Film No.: 18745701
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 212-651-6380
Aisling Capital IV, LP (Filed by) CIK: 0001652910 (see all company filings)

IRS No.: 474953768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G